Skip to main content

Breadcrumb

  1. Home

Registry data

Anti-Lipid Treatment Discharge

  • Percent of patients aged 18 years and older undergoing isolated CABG who were discharged on a lipid lowering statin

    CBE ID
    0118

Asthma: Pharmacologic Therapy for Persistent Asthma

  • Percentage of patients aged 5 years and older with a diagnosis of persistent asthma who were prescribed long-term control medication

    Three rates are reported for this measure:
    1. Patients prescribed inhaled corticosteroids (ICS) as their long term control medication
    2. Patients prescribed other alternative long term control medications (non-ICS)
    3. Total patients prescribed long-term control medication

    CBE ID
    0047

Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy

  • Percentage of patients aged 18 years and older with a diagnosis of nonvalvular atrial fibrillation (AF) or atrial flutter whose assessment of the specified thromboembolic risk factors indicate one or more high-risk factors or more than one moderate risk factor, as determined by CHADS2 risk stratification, who are prescribed warfarin OR another oral anticoagulant drug that is FDA approved for the prevention of thromboembolism

    CBE ID
    1525

Beta Blockade at Discharge

  • Percent of patients aged 18 years and older undergoing isolated CABG who were discharged on beta blockers

    CBE ID
    0117